About this FactMed analysis covering adverse side effect reports of ALIZAPRIDE patients who developed STOMATITIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking ALIZAPRIDE reported STOMATITIS to the FDA. A total of 102 ALIZAPRIDE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALIZAPRIDE and STOMATITIS. In doing so, we compare ALIZAPRIDE with other drugs that cause STOMATITIS, to help you evaluate whether or not ALIZAPRIDE causes STOMATITIS. Likewise, this page shows the most highly-reported side effects of ALIZAPRIDE, so you can see if STOMATITIS ranks among ALIZAPRIDE's most well-known side effects.
Summary Statistics
Reports of ALIZAPRIDE causing STOMATITIS: 1
Reports of any side effect of ALIZAPRIDE : 102
Percentage of ALIZAPRIDE patients where STOMATITIS is a reported side effect: 0.9804%

FDA reports of any drug causing STOMATITIS : 13344
Average percentage for all medicated patients where STOMATITIS is reported as a complication: 0.0836%

Physician opinion on ALIZAPRIDE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALIZAPRIDE:
DRUG USE FOR UNKNOWN INDICATION ( 14 patients )
NAUSEA ( 14 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 3 patients )
PREMEDICATION ( 2 patients )
VOMITING ( 2 patients )
ANTIEMETIC SUPPORTIVE CARE ( 2 patients )
PROPHYLAXIS ( 1 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with STOMATITIS:

FOSAMAX (2156 patients)
FLUOROURACIL (1335 patients)
ZOMETA (1191 patients)
NEXAVAR (1008 patients)
METHOTREXATE (952 patients)
ASPIRIN (712 patients)
XELODA (682 patients)
CISPLATIN (675 patients)
AREDIA (633 patients)
PREDNISOLONE (620 patients)
LASIX (597 patients)
DECADRON (590 patients)
PREDNISONE (551 patients)
PANITUMUMAB (543 patients)
DOXORUBICIN HCL (536 patients)
CYCLOPHOSPHAMIDE (531 patients)
DEXAMETHASONE (517 patients)
SUTENT (490 patients)
HUMIRA (488 patients)
NEXIUM (469 patients)
AVASTIN (444 patients)
FOLIC ACID (434 patients)
OXYCONTIN (421 patients)
AFINITOR (417 patients)
TAXOTERE (407 patients)
OMEPRAZOLE (393 patients)
OXALIPLATIN (389 patients)
XANAX (381 patients)
SYNTHROID (381 patients)
LEUCOVORIN CALCIUM (381 patients)
RADIATION THERAPY (372 patients)
COUMADIN (361 patients)
AMBIEN (356 patients)
CAPECITABINE (352 patients)
REVLIMID (351 patients)
PROTONIX (350 patients)
ZOFRAN (344 patients)
ENBREL (338 patients)
PRILOSEC (312 patients)
NEURONTIN (309 patients)
ALLOPURINOL (305 patients)
NORVASC (303 patients)
REMICADE (302 patients)
LIPITOR (299 patients)
VINCRISTINE (297 patients)
LISINOPRIL (288 patients)
ACETAMINOPHEN (279 patients)
PEGASYS (275 patients)
ZANTAC (273 patients)
HYDROCHLOROTHIAZIDE (269 patients)
CARBOPLATIN (267 patients)
FUROSEMIDE (264 patients)
CYCLOSPORINE (257 patients)
LYRICA (254 patients)
ATIVAN (253 patients)
DOCETAXEL (252 patients)
SANDOSTATIN LAR (248 patients)
VICODIN (247 patients)
FAMOTIDINE (245 patients)
TYKERB (242 patients)
ERBITUX (241 patients)
ATENOLOL (241 patients)
LEVAQUIN (241 patients)
CELEBREX (237 patients)
LEVOTHYROXINE SODIUM (236 patients)
IRINOTECAN HCL (231 patients)
ETOPOSIDE (230 patients)
NEUPOGEN (229 patients)
COMPAZINE (229 patients)
PERCOCET (227 patients)
LAMICTAL (227 patients)
SIMVASTATIN (226 patients)
ACYCLOVIR (225 patients)
BONIVA (223 patients)
CYTARABINE (222 patients)
CALCIUM (221 patients)
PREVACID (221 patients)
POTASSIUM CHLORIDE (221 patients)
KYTRIL (219 patients)
ADVAIR DISKUS 100/50 (219 patients)
CYMBALTA (219 patients)
PREDNISONE TAB (214 patients)
OXYCODONE HCL (214 patients)
ZOLOFT (214 patients)
RIBAVIRIN (209 patients)
SPIRIVA (208 patients)
LANSOPRAZOLE (208 patients)
ALBUTEROL (207 patients)
PROGRAF (204 patients)
DIOVAN (201 patients)
CHANTIX (200 patients)
LORAZEPAM (199 patients)
DIFLUCAN (197 patients)
VIOXX (196 patients)
VITAMIN D (194 patients)
CERTICAN (194 patients)
BENADRYL (194 patients)
BUSULFEX (193 patients)
LOXONIN (191 patients)
ZOCOR (191 patients)
TACROLIMUS (190 patients)
RHEUMATREX (190 patients)
DILAUDID (188 patients)
TAMOXIFEN CITRATE (188 patients)
MORPHINE (187 patients)
DURAGESIC-100 (185 patients)
BEVACIZUMAB (184 patients)
FLUCONAZOLE (183 patients)
FLEXERIL (183 patients)
CETUXIMAB (180 patients)
MULTI-VITAMINS (179 patients)
GABAPENTIN (177 patients)
PLAVIX (176 patients)
HERCEPTIN (175 patients)
MUCOSTA (172 patients)
FLUDARABINE PHOSPHATE (172 patients)
AMOXICILLIN (171 patients)
FORTEO (171 patients)
TAXOL (170 patients)
GLEEVEC (168 patients)
DEXAMETHASONE SODIUM PHOSPHATE (168 patients)
SEROQUEL (168 patients)
NYSTATIN (168 patients)
BACTRIM (166 patients)
PROZAC (166 patients)
TOPROL-XL (162 patients)
CYTOXAN (161 patients)
ELAVIL (161 patients)
CRESTOR (159 patients)
CALCIUM LEVOFOLINATE (159 patients)
LEXAPRO (158 patients)
CORTICOSTEROIDS (155 patients)
AMLODIPINE (155 patients)
DOXIL (155 patients)
FENTANYL (154 patients)
FASLODEX (154 patients)
IBUPROFEN (154 patients)
PAXIL (153 patients)
RITUXIMAB (151 patients)
VITAMIN B-12 (150 patients)
FLAGYL (150 patients)
CIPROFLOXACIN (150 patients)
ALPRAZOLAM (150 patients)
REGLAN (149 patients)
VANCOMYCIN (147 patients)
FLONASE (145 patients)
ACTONEL (145 patients)
FEMARA (143 patients)
CELEXA (143 patients)
AUGMENTIN '125' (142 patients)
SINGULAIR (142 patients)
TEGRETOL (142 patients)
COZAAR (142 patients)
ARIMIDEX (141 patients)
PREMARIN (141 patients)
PEPCID (141 patients)
ALENDRONATE SODIUM (140 patients)
FOSAMAX PLUS D (140 patients)
MAGNESIUM OXIDE (139 patients)
PREDONINE (139 patients)
ZITHROMAX (138 patients)
PERIDEX (138 patients)
IRESSA (136 patients)
TOCILIZUMAB (136 patients)
CHEMOTHERAPEUTICS NOS (135 patients)
CLINDAMYCIN (135 patients)
PACLITAXEL (133 patients)
RANITIDINE (133 patients)
MS CONTIN (133 patients)
COLACE (131 patients)
MOBIC (130 patients)
CLONAZEPAM (130 patients)
METFORMIN HCL (130 patients)
VITAMIN E (129 patients)
PROVIGIL (129 patients)
GEMZAR (129 patients)
THALIDOMIDE (128 patients)
NEORAL (128 patients)
ERLOTINIB HYDROCHLORIDE (128 patients)
MAGNESIUM SULFATE (128 patients)
ALLEGRA (128 patients)
ADRIAMYCIN PFS (128 patients)
METOPROLOL TARTRATE (126 patients)
ZOVIRAX (124 patients)
VALPROATE SODIUM (124 patients)
URSO 250 (124 patients)
ARANESP (123 patients)
MULTI-VITAMIN (123 patients)
LEVOFLOXACIN (120 patients)
LORTAB (119 patients)
EFFEXOR (119 patients)
PEG-INTRON (118 patients)
VELCADE (118 patients)
MAGMITT (118 patients)
KEFLEX (117 patients)
NAPROXEN (116 patients)
ZYRTEC (116 patients)
IRINOTECAN HYDROCHLORIDE (115 patients)
FERROUS SULFATE TAB (115 patients)
TYSABRI (115 patients)
AVELOX (115 patients)
EVISTA (114 patients)
WARFARIN SODIUM (112 patients)
COPEGUS (112 patients)
ROCEPHIN (112 patients)
RADIOTHERAPY (111 patients)
SORAFENIB (RAF KINASE INHIBITOR) (111 patients)
BEXTRA (110 patients)
RESTORIL (110 patients)
AMITRIPTYLINE HCL (110 patients)
Most common side effects for patients taking ALIZAPRIDE:
DIARRHOEA (16 patients)
PYREXIA (16 patients)
VOMITING (10 patients)
FATIGUE (9 patients)
HYPOKALAEMIA (9 patients)
DEHYDRATION (8 patients)
NAUSEA (7 patients)
ANAEMIA (6 patients)
ASTHENIA (6 patients)
BRONCHOPNEUMONIA (6 patients)
DRUG INTERACTION (6 patients)
DYSPNOEA (6 patients)
HYPOTENSION (6 patients)
PNEUMONIA (6 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (5 patients)
HAEMORRHAGE (5 patients)
HYPOMAGNESAEMIA (5 patients)
HYPOPHOSPHATAEMIA (5 patients)
JAUNDICE (5 patients)
RESPIRATORY FAILURE (5 patients)
SOMNOLENCE (5 patients)
TACHYCARDIA (5 patients)
ABDOMINAL PAIN (4 patients)
ADVERSE DRUG REACTION (4 patients)
FALL (4 patients)
HAEMODIALYSIS (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
INTESTINAL OBSTRUCTION (4 patients)
MALAISE (4 patients)
SLEEP APNOEA SYNDROME (4 patients)
SUPRAVENTRICULAR TACHYCARDIA (4 patients)
THROMBOCYTHAEMIA (4 patients)
THROMBOCYTOPENIA (4 patients)
WHITE BLOOD CELL COUNT DECREASED (4 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (3 patients)
BACTERIAL SEPSIS (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
BLOOD CREATININE INCREASED (3 patients)
DECREASED APPETITE (3 patients)
DERMATITIS EXFOLIATIVE (3 patients)
DEVICE DISLOCATION (3 patients)
ENTERITIS (3 patients)
FEBRILE NEUTROPENIA (3 patients)
FIBRIN D DIMER INCREASED (3 patients)
FUSOBACTERIUM INFECTION (3 patients)
HAEMOPTYSIS (3 patients)
HYPOXIA (3 patients)
ILEUS (3 patients)
LEUKAEMIA RECURRENT (3 patients)
MUCOSAL INFLAMMATION (3 patients)
NEUROTOXICITY (3 patients)
NEUTROPENIA (3 patients)
OVERDOSE (3 patients)
PRESYNCOPE (3 patients)
PROTEUS INFECTION (3 patients)
RASH (3 patients)
RENAL FAILURE ACUTE (3 patients)
SEPTIC SHOCK (3 patients)
SUPERINFECTION (3 patients)
TONGUE DISORDER (3 patients)
ACUTE PULMONARY OEDEMA (2 patients)
AGRANULOCYTOSIS (2 patients)
ATRIAL FIBRILLATION (2 patients)
BLOOD FIBRINOGEN INCREASED (2 patients)
BLOOD GLUCOSE INCREASED (2 patients)
BONE MARROW DEPRESSION (2 patients)
BONE MARROW FAILURE (2 patients)
BRONCHOPULMONARY ASPERGILLOSIS (2 patients)
C-REACTIVE PROTEIN INCREASED (2 patients)
CHILLS (2 patients)
COLITIS ISCHAEMIC (2 patients)
CONSTIPATION (2 patients)
CONVULSION (2 patients)
CORONARY ARTERY DISEASE (2 patients)
DEAFNESS (2 patients)
DIZZINESS (2 patients)
DRUG ADMINISTRATION ERROR (2 patients)
DYSPHAGIA (2 patients)
DYSURIA (2 patients)
EJECTION FRACTION DECREASED (2 patients)
ERYSIPELAS (2 patients)
FACIAL PALSY (2 patients)
FEBRILE BONE MARROW APLASIA (2 patients)
FLATULENCE (2 patients)
GASTROENTERITIS (2 patients)
HAEMATOCRIT DECREASED (2 patients)
HYPERSENSITIVITY (2 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (2 patients)
INFECTION (2 patients)
KLEBSIELLA SEPSIS (2 patients)
LEUKOPENIA (2 patients)
LYMPHANGITIS (2 patients)
LYMPHOCYTE COUNT INCREASED (2 patients)
NERVOUS SYSTEM DISORDER (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
OEDEMA MUCOSAL (2 patients)
OTITIS MEDIA (2 patients)
PANCYTOPENIA (2 patients)
PARTIAL SEIZURES (2 patients)
PLATELET COUNT DECREASED (2 patients)
PULMONARY EMBOLISM (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE (2 patients)
RHINORRHOEA (2 patients)
SHOCK (2 patients)
STREPTOCOCCAL SEPSIS (2 patients)
SUDDEN CARDIAC DEATH (2 patients)
URTICARIA (2 patients)
ACCIDENTAL OVERDOSE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (1 patients)
AGITATION (1 patients)
ALVEOLITIS (1 patients)
ANOREXIA (1 patients)
ANXIETY (1 patients)
APHASIA (1 patients)
APHTHOUS STOMATITIS (1 patients)
ARACHNOIDITIS (1 patients)
BLOOD CULTURE POSITIVE (1 patients)
CALCULUS URINARY (1 patients)
CANDIDA SEPSIS (1 patients)
CANDIDIASIS (1 patients)
CARDIO-RESPIRATORY ARREST (1 patients)
CENTRAL NERVOUS SYSTEM LEUKAEMIA (1 patients)
CEREBRAL HAEMORRHAGE (1 patients)
CHEST PAIN (1 patients)
COLITIS (1 patients)
CONFUSIONAL STATE (1 patients)
COUGH (1 patients)
CYANOSIS (1 patients)
DIARRHOEA INFECTIOUS (1 patients)
DISEASE PROGRESSION (1 patients)
DISLOCATION OF VERTEBRA (1 patients)
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG TOXICITY (1 patients)
DRY SKIN (1 patients)
ENCEPHALOPATHY (1 patients)
EPILEPSY (1 patients)
ERYTHEMA (1 patients)
FLUSHING (1 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (1 patients)
GENERAL PHYSICAL CONDITION ABNORMAL (1 patients)
GRAFT VERSUS HOST DISEASE (1 patients)
HAEMATURIA (1 patients)
HEADACHE (1 patients)
HYPERBILIRUBINAEMIA (1 patients)
HYPERTENSIVE CRISIS (1 patients)
HYPOACUSIS (1 patients)
HYPOAESTHESIA (1 patients)
HYPOCALCAEMIA (1 patients)
HYPOMANIA (1 patients)
HYPOVOLAEMIC SHOCK (1 patients)
KLEBSIELLA INFECTION (1 patients)
LACTOSE INTOLERANCE (1 patients)
LEUKAEMIA PLASMACYTIC (1 patients)
METASTATIC NEOPLASM (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE MYELOMA (1 patients)
MUSCULAR WEAKNESS (1 patients)
MYALGIA (1 patients)
MYOGLOBIN BLOOD INCREASED (1 patients)
NEOPLASM (1 patients)
NEURALGIA (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PAIN (1 patients)
PARESIS (1 patients)
PNEUMONIA KLEBSIELLA (1 patients)
PNEUMONITIS (1 patients)
PRODUCTIVE COUGH (1 patients)
PRURITUS (1 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (1 patients)
PULMONARY HYPERTENSION (1 patients)
RADIUS FRACTURE (1 patients)
RASH GENERALISED (1 patients)
RASH MACULAR (1 patients)
RASH MACULO-PAPULAR (1 patients)
RENAL COLIC (1 patients)
RESPIRATORY DISTRESS (1 patients)
RIGHT VENTRICULAR DYSFUNCTION (1 patients)
SEPSIS (1 patients)
SKIN LESION (1 patients)
SPUTUM PURULENT (1 patients)
STAPHYLOCOCCAL BACTERAEMIA (1 patients)
STEM CELL TRANSPLANT (1 patients)
STOMATITIS (1 patients)
THROMBOSIS (1 patients)
THROMBOTIC MICROANGIOPATHY (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
ULNA FRACTURE (1 patients)
WEIGHT DECREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALIZAPRIDE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about STOMATITIS and ALIZAPRIDE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALIZAPRIDE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALIZAPRIDE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALIZAPRIDE experts. If you are a healthcare provider experienced in prescribing ALIZAPRIDE, please register here.

Your online appointment book for Lucedale Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use